AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?

digital therapeutics 52

digital therapeutics health accelerator board 52

TechCrunch

FEBRUARY 10, 2022

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. The COVID-19 pandemic accelerated the company’s growth. million Series B, which was three times oversubscribed within two months.

health 83

health digital therapeutics accelerator venture capital 83

American Entrepreneurship

JANUARY 18, 2024

By granting the fellows the financial freedom to focus entirely on their businesses, NJIF is providing an opportunity to accelerate their success.” The company will focus on building its digital proprietary platform and easy-to-use digital application.

innovation 52

innovation mentorship economic development entrepreneurship 52